GRAPHIC-跡をつけるing the ワクチン race
Nov 9 (Reuters) - The race to create ワクチンs against the novel coronavirus is entering a 批判的な stretch, with several 候補者s that were first out of the gate beginning to 解放（する） late-行う／開催する／段階 裁判，公判 data.
Pfizer Inc and its partner BioNTech SE said on Monday their 実験の COVID-19 ワクチン is more than 90% 効果的な based on 初期の 裁判，公判 results, a much higher efficacy 率 than the 50% 最小限 要求するd by the U.S. Food and 麻薬 行政.
多重の ワクチンs are likely to make it to market and success will depend on a number of factors, 含むing 免疫の 返答, safety and 配当.
Reuters is 跡をつけるing the 候補者s closest to producing results in this tracker: https://tmsnrt.rs/36jDuuj (報告（する）／憶測ing by Christine 急に上がるs, Editing by Tiffany Wu)
